Structure |
Chemical Name |
CAS |
MF |
![Ibuprofen IPA impurity](/) |
Ibuprofen IPA impurity |
|
|
![Voriconazole Impurity 19](/CAS/20210111/GIF/321589-01-9.gif) |
Voriconazole Impurity 19 |
321589-01-9 |
C26H28F3N5O4S |
![Gadobutrol Impurity 4 (Gd-DOTA)](/) |
Gadobutrol Impurity 4 (Gd-DOTA) |
|
|
![Losartan Impurity 3](/) |
Losartan Impurity 3 |
|
|
![Cilastatin EP Impurity G](/) |
Cilastatin EP Impurity G |
|
|
![Rosuvastatin Impurity 122](/CAS/20210111/GIF/135999-58-5.gif) |
Rosuvastatin Impurity 122 |
135999-58-5 |
C6H7ClO3 |
![NA](/) |
NA |
|
|
![NA](/) |
NA |
|
|
![Tinidazole Impurity B](/) |
Tinidazole Impurity B |
|
|
![Nimodipine Metabolite 3](/CAS/20210111/GIF/82219-48-5.gif) |
Nimodipine Metabolite 3 |
82219-48-5 |
C20H22N2O7 |
![N-DEMETHYLROXITHROMYCIN](/CAS/GIF/118267-18-8.gif) |
N-DEMETHYLROXITHROMYCIN |
118267-18-8 |
C40H74N2O15 |
![SULPIRIDE IMPURITY A](/) |
SULPIRIDE IMPURITY A |
|
|
![Androst-2-en-17-one, (5β)-](/CAS/20211123/GIF/82467-84-3.gif) |
Androst-2-en-17-one, (5β)- |
82467-84-3 |
C19H28O |
![(6α,11β)-11,21-Dihydroxy-6-methyl-pregna-1,4-diene-3,20-dione](/CAS/20210305/GIF/103744-18-9.gif) |
(6α,11β)-11,21-Dihydroxy-6-methyl-pregna-1,4-diene-3,20-dione |
103744-18-9 |
C22H30O4 |
![2,5-Thiazolylmethyl Diacarbonate](/) |
2,5-Thiazolylmethyl Diacarbonate |
144142-33-6 |
C28H30N4O5S2 |
![4-(2-Chloroethyl)-N-methoxy-N,α,α-trimethyl-benzeneacetamide](/CAS/20210305/GIF/1638785-17-7.gif) |
4-(2-Chloroethyl)-N-methoxy-N,α,α-trimethyl-benzeneacetamide |
1638785-17-7 |
C14H20ClNO2 |
![Cefuroxime Impurity A Double-Bond Shift Impurity](/) |
Cefuroxime Impurity A Double-Bond Shift Impurity |
|
|
![4-(difluoromethoxy)-N1-((3,4-dimethoxypyridin-2-yl)methyl)benzene-1,2-diamine](/CAS/20210305/GIF/2641896-99-1.gif) |
4-(difluoromethoxy)-N1-((3,4-dimethoxypyridin-2-yl)methyl)benzene-1,2-diamine |
2641896-99-1 |
C15H17F2N3O3 |
![Peramivir Impurity 21](/) |
Peramivir Impurity 21 |
|
|
![Dapagliflozin Impurity 165](/CAS/20210111/GIF/342043-51-0.gif) |
Dapagliflozin Impurity 165 |
342043-51-0 |
C18H18O4 |
![3'-Desethoxy Drotaverine Hydrochloride](/CAS/20210111/GIF/85475-87-2.gif) |
3'-Desethoxy Drotaverine Hydrochloride |
85475-87-2 |
C22H28ClNO4 |
![(S)-dimethyl 2-(4-(4-oxobutyl)benzamido)pentanedioate](/CAS/20210111/GIF/1081974-98-2.gif) |
(S)-dimethyl 2-(4-(4-oxobutyl)benzamido)pentanedioate |
1081974-98-2 |
C18H23NO6 |
![Peramivir Impurity 38](/) |
Peramivir Impurity 38 |
|
|
![(3S)-3-((S)-1-oxo-3a,4,5,6-tetrahydro-1H-benzo[de]isoquinolin-2(3H)-yl)quinuclidine 1-oxide](/) |
(3S)-3-((S)-1-oxo-3a,4,5,6-tetrahydro-1H-benzo[de]isoquinolin-2(3H)-yl)quinuclidine 1-oxide |
|
|
![2-(4-hydroxy-1-methyl-7-phenoxy-5,6,7,8-tetrahydroisoquinoline-3-carboxamido)acetic acid](/) |
2-(4-hydroxy-1-methyl-7-phenoxy-5,6,7,8-tetrahydroisoquinoline-3-carboxamido)acetic acid |
|
|
![6-HYDROXYLAMINOURACIL](/CAS/GIF/20555-88-8.gif) |
6-HYDROXYLAMINOURACIL |
20555-88-8 |
C4H5N3O2 |
![Dapagliflozin](/CAS/20211123/GIF/639852-30-5.gif) |
Dapagliflozin |
639852-30-5 |
C19H44O5Si4 |
![Cabozantinib impurity 52](/) |
Cabozantinib impurity 52 |
|
|
![Canagliflozin Impurity 71](/) |
Canagliflozin Impurity 71 |
|
|
![N-((4-(5-methyl-2-phenyloxazol-4-yl)phenyl)sulfonyl)propionamide](/CAS/20210111/GIF/2242749-02-4.gif) |
N-((4-(5-methyl-2-phenyloxazol-4-yl)phenyl)sulfonyl)propionamide |
2242749-02-4 |
C19H18N2O4S |
![Dapoxetine impurity 67](/) |
Dapoxetine impurity 67 |
|
|
![FENOFIBRIC ACID ETHYL ESTER](/CAS/GIF/42019-08-9.gif) |
FENOFIBRIC ACID ETHYL ESTER |
42019-08-9 |
C19H19ClO4 |
![2-(5-Acetyl-2-ethoxyphenyl)-5-methyl-7-propyl-imidazo[5,1-f][1,2,4]triazin-4(1H)-one](/CAS/20210111/GIF/358390-43-9.gif) |
2-(5-Acetyl-2-ethoxyphenyl)-5-methyl-7-propyl-imidazo[5,1-f][1,2,4]triazin-4(1H)-one |
358390-43-9 |
C19H22N4O3 |
![Empagliflozin Impurity 80](/) |
Empagliflozin Impurity 80 |
|
|
![Empagliflozin Impurity 92](/) |
Empagliflozin Impurity 92 |
|
|
![Iohexol Impurity N](/) |
Iohexol Impurity N |
|
|
![Pitavastatin 5-Oxo Impurity Calcium Salt](/CAS/20211123/GIF/2180095-22-9.gif) |
Pitavastatin 5-Oxo Impurity Calcium Salt |
2180095-22-9 |
C25H24CaFNO4 |
![1-(2-bromo-3,5-dihydroxyphenyl)ethanone](/CAS/20210111/GIF/2092614-65-6.gif) |
1-(2-bromo-3,5-dihydroxyphenyl)ethanone |
2092614-65-6 |
C8H7BrO3 |
![Lenvatinib impurity LFZZ-18](/CAS/20181212/GIF/CB48058140.gif) |
Lenvatinib impurity LFZZ-18 |
|
C11H8Cl2N2O2 |
![Rosuvastatin Impurity 121](/CAS/20210111/GIF/140164-51-8.gif) |
Rosuvastatin Impurity 121 |
140164-51-8 |
C10H18O5 |
![Brivaracetam Impurity 38](/) |
Brivaracetam Impurity 38 |
|
|
![Isavuconazole Impurities 04](/) |
Isavuconazole Impurities 04 |
|
|
![Ticagrelor Impurity 119](/) |
Ticagrelor Impurity 119 |
|
|
![Ticagrelor Impurity 118](/) |
Ticagrelor Impurity 118 |
|
|
![D-erythro-Hexonic acid, 2,4-dideoxy-3,5-O-(1-methylethylidene)-, acetate (9CI)](/CAS/20200611/GIF/402508-35-4.gif) |
D-erythro-Hexonic acid, 2,4-dideoxy-3,5-O-(1-methylethylidene)-, acetate (9CI) |
402508-35-4 |
C11H18O6 |
![L-Alanine, 3-[(S)-(carboxymethyl)sulfinyl]-](/CAS/20200611/GIF/112246-66-9.gif) |
L-Alanine, 3-[(S)-(carboxymethyl)sulfinyl]- |
112246-66-9 |
C5H9NO5S |
![2-Propanone, 1-[4,5-dihydro-2-(4-methyl-1-piperazinyl)-4-thioxo-3H-1,5-benzodiazepin-3-ylidene]-](/CAS/20200611/GIF/1902955-67-2.gif) |
2-Propanone, 1-[4,5-dihydro-2-(4-methyl-1-piperazinyl)-4-thioxo-3H-1,5-benzodiazepin-3-ylidene]- |
1902955-67-2 |
C17H20N4OS |
![3(2H)-Pyridazinone, 6-[4-(ethylamino)phenyl]-4,5-dihydro-5-methyl-](/CAS/20200611/GIF/52240-42-3.gif) |
3(2H)-Pyridazinone, 6-[4-(ethylamino)phenyl]-4,5-dihydro-5-methyl- |
52240-42-3 |
C13H17N3O |
![Benzoic acid, 4-[[4-(aminocarbonyl)-1-piperidinyl]methyl]-](/CAS/20200611/GIF/938143-02-3.gif) |
Benzoic acid, 4-[[4-(aminocarbonyl)-1-piperidinyl]methyl]- |
938143-02-3 |
C14H18N2O3 |
![1-(4-methylbenzyl)-1,4,8,11-tetraazacyclotetradecane tetrahydrochloride](/) |
1-(4-methylbenzyl)-1,4,8,11-tetraazacyclotetradecane tetrahydrochloride |
|
|
![2,4-bis(1-(2,3-dimethylphenyl)ethyl)-1H-imidazole](/) |
2,4-bis(1-(2,3-dimethylphenyl)ethyl)-1H-imidazole |
|
|
![2-((4R,6S)-6-((2-((4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetoxy)methyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetic acid](/) |
2-((4R,6S)-6-((2-((4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetoxy)methyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetic acid |
|
|
![1,3-bis(4-((E)-3-methoxy-3-oxoprop-1-en-1-yl)benzyl)-1H-imidazol-3-ium bromide](/) |
1,3-bis(4-((E)-3-methoxy-3-oxoprop-1-en-1-yl)benzyl)-1H-imidazol-3-ium bromide |
|
|
![Crisaborole intermediate](/CAS/20210111/GIF/1187230-70-1.gif) |
Crisaborole intermediate |
1187230-70-1 |
C14H14BNO3 |
![Glycine, (2R)-N-[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]-2-phenylglycyl-2-[(2S,4S)-4-carboxy-5,5-dimethyl-2-thiazolidinyl]-, (2R)-](/CAS/20210111/GIF/1449784-97-7.gif) |
Glycine, (2R)-N-[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]-2-phenylglycyl-2-[(2S,4S)-4-carboxy-5,5-dimethyl-2-thiazolidinyl]-, (2R)- |
1449784-97-7 |
C23H29N5O8S |
![6-Quinolinecarboxamide, 4-[(2-chloro-4-hydroxyphenyl)amino]-7-methoxy-](/CAS/20210111/GIF/2380197-89-5.gif) |
6-Quinolinecarboxamide, 4-[(2-chloro-4-hydroxyphenyl)amino]-7-methoxy- |
2380197-89-5 |
C17H14ClN3O3 |
![1-Pyrrolidineacetic acid, α-ethyl-2-oxo-4-propyl-, methyl ester, (4R)-](/CAS/20211123/GIF/930123-52-7.gif) |
1-Pyrrolidineacetic acid, α-ethyl-2-oxo-4-propyl-, methyl ester, (4R)- |
930123-52-7 |
C12H21NO3 |
![Traxipide impurity](/) |
Traxipide impurity |
|
|
![Benzeneacetic acid, 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl]ethyl]-α,α-dimethyl-, methyl ester](/CAS/20210305/GIF/1181267-38-8.gif) |
Benzeneacetic acid, 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl]ethyl]-α,α-dimethyl-, methyl ester |
1181267-38-8 |
C29H39N3O3 |
![Benzenemethanol, 4-[2-(1-methylethoxy)ethoxy]-](/CAS/20210111/GIF/1039828-27-7.gif) |
Benzenemethanol, 4-[2-(1-methylethoxy)ethoxy]- |
1039828-27-7 |
C12H18O3 |
![Brivaracetam Impurity 7 HCl](/CAS/20211123/GIF/357338-46-6.gif) |
Brivaracetam Impurity 7 HCl |
357338-46-6 |
C13H27ClN2O3 |
![Bisacodyl Impurity 1](/CAS/20210111/GIF/13004-51-8.gif) |
Bisacodyl Impurity 1 |
13004-51-8 |
C18H15NO2 |
![Vecuronium Bromide ImpurityACDEFGHJKL](/) |
Vecuronium Bromide ImpurityACDEFGHJKL |
|
|
![Butanedioic acid, 2-[[2-methyl-1-(phenylmethyl)-1H-imidazol-5-yl]methylene]-, 1-ethyl ester, (2E)-](/CAS/20210111/GIF/1640981-02-7.gif) |
Butanedioic acid, 2-[[2-methyl-1-(phenylmethyl)-1H-imidazol-5-yl]methylene]-, 1-ethyl ester, (2E)- |
1640981-02-7 |
C18H20N2O4 |
![INDEX NAME NOT YET ASSIGNED](/CAS/20211123/GIF/2452300-94-4.gif) |
INDEX NAME NOT YET ASSIGNED |
2452300-94-4 |
C21H25ClO8 |
![1-Butanone, 1-(4-fluorophenyl)-4-[(6bS,10aS)-2,3,6b,9,10,10a-hexahydro-3-methyl-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl]-](/CAS/20200611/GIF/1576240-15-7.gif) |
1-Butanone, 1-(4-fluorophenyl)-4-[(6bS,10aS)-2,3,6b,9,10,10a-hexahydro-3-methyl-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl]- |
1576240-15-7 |
C24H28FN3O |
![1-Pyrrolidineacetamide, α-ethyl-4-(1-methylethyl)-2-oxo-, (αS,4S)-](/CAS/20211123/GIF/357334-83-9.gif) |
1-Pyrrolidineacetamide, α-ethyl-4-(1-methylethyl)-2-oxo-, (αS,4S)- |
357334-83-9 |
C11H20N2O2 |
![impurity 42](/) |
impurity 42 |
|
|
![2,2'-(4,10-bis((2S,3R)-1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,7-diyl)diacetic acid](/) |
2,2'-(4,10-bis((2S,3R)-1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,7-diyl)diacetic acid |
|
|
![Loratadine Impurity 2](/CAS/20200611/GIF/167891-69-2.gif) |
Loratadine Impurity 2 |
167891-69-2 |
C22H25ClN2O2 |
![Eliglustat (1S,2S)-Isomer (Hemitartrate)](/CAS/20200611/GIF/1092472-70-2.gif) |
Eliglustat (1S,2S)-Isomer (Hemitartrate) |
1092472-70-2 |
C23H36N2O4 |
![3-Azetidineacetic acid, 1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-](/CAS/20210111/GIF/2271228-52-3.gif) |
3-Azetidineacetic acid, 1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]- |
2271228-52-3 |
C16H18N6O4S |
![Cyclopentanecarboxylic acid, 3-[(1S)-1-amino-2-ethylbutyl]-4-[(aminoiminomethyl)amino]-2-hydroxy-, (1S,2S,3S,4R)-](/CAS/20210111/GIF/2412376-06-6.gif) |
Cyclopentanecarboxylic acid, 3-[(1S)-1-amino-2-ethylbutyl]-4-[(aminoiminomethyl)amino]-2-hydroxy-, (1S,2S,3S,4R)- |
2412376-06-6 |
C13H26N4O3 |
![Peramivir Impurity 49](/) |
Peramivir Impurity 49 |
2758048-81-4 |
|
![1-Pyrrolidinecarboxylic acid, 3,3'-dithiobis[5-[[(3-carboxyphenyl)amino]carbonyl]-, 1,1'-bis[(4-nitrophenyl)methyl] ester, (3S,3'S,5S,5'S)-](/CAS/20211123/GIF/1401451-19-1.gif) |
1-Pyrrolidinecarboxylic acid, 3,3'-dithiobis[5-[[(3-carboxyphenyl)amino]carbonyl]-, 1,1'-bis[(4-nitrophenyl)methyl] ester, (3S,3'S,5S,5'S)- |
1401451-19-1 |
C40H36N6O14S2 |
![Benzeneacetic acid, α-(hydroxymethyl)-, 9-butyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl ester, [7(S)-(1α,2β,4β,5α,7β)]- (9CI)](/CAS/20210305/GIF/14861-14-4.gif) |
Benzeneacetic acid, α-(hydroxymethyl)-, 9-butyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl ester, [7(S)-(1α,2β,4β,5α,7β)]- (9CI) |
14861-14-4 |
C20H27NO4 |
![Cisatracurium besylate impurity 18](/) |
Cisatracurium besylate impurity 18 |
|
|
![Paclitaxel Impurity1 ABCDEFGHJKL](/) |
Paclitaxel Impurity1 ABCDEFGHJKL |
|
|
![3-THIOPHENEPROPANAMINE, N,N-DIMETHYL-GAMMA-(1-NAPHTHALENYLOXY)-, ETHANEDIOATE(1:1)](/CAS/GIF/116817-26-6.gif) |
3-THIOPHENEPROPANAMINE, N,N-DIMETHYL-GAMMA-(1-NAPHTHALENYLOXY)-, ETHANEDIOATE(1:1) |
116817-26-6 |
C21H23NO5S |
![(2R,3S/2S,3R)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol](/CAS/GIF/182230-43-9.gif) |
(2R,3S/2S,3R)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol |
182230-43-9 |
C16H14F3N5O |
![Bumetanide Impurity 8](/) |
Bumetanide Impurity 8 |
|
|
![Benzenesulfonamide, N-(2-aminoethyl)-3-(1,4-dihydro-5-methyl-4-oxo-7-propylimidazo[5,1-f][1,2,4]triazin-2-yl)-4-ethoxy-](/CAS/20210305/GIF/448184-52-9.gif) |
Benzenesulfonamide, N-(2-aminoethyl)-3-(1,4-dihydro-5-methyl-4-oxo-7-propylimidazo[5,1-f][1,2,4]triazin-2-yl)-4-ethoxy- |
448184-52-9 |
C19H26N6O4S |
![Latamoxef Impurity C](/) |
Latamoxef Impurity C |
|
|
![Carbamic acid, [2-hydroxy-1-methyl-2-[3-(phenylmethoxy)phenyl]ethyl]-, phenylmethyl ester, [R-(R*,S*)]- (9CI)](/CAS/20210305/GIF/31301-86-7.gif) |
Carbamic acid, [2-hydroxy-1-methyl-2-[3-(phenylmethoxy)phenyl]ethyl]-, phenylmethyl ester, [R-(R*,S*)]- (9CI) |
31301-86-7 |
C24H25NO4 |
![9H-Purine-9-ethanol, 6-amino-β-methyl-](/CAS/20211123/GIF/20776-34-5.gif) |
9H-Purine-9-ethanol, 6-amino-β-methyl- |
20776-34-5 |
C8H11N5O |
![2-amino-5-[(3,4,5-trimethoxyphenyl)methyl]-1H-pyrimidin-4-one](/CAS/GIF/92440-76-1.gif) |
2-amino-5-[(3,4,5-trimethoxyphenyl)methyl]-1H-pyrimidin-4-one |
92440-76-1 |
C14H17N3O4 |
![(S)-3-(3-((3-chloro-2-(3,4-dimethoxyphenyl)propyl)(methyl)amino) propyl)-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-benzo[d]azepin-2-one hydrochloride](/) |
(S)-3-(3-((3-chloro-2-(3,4-dimethoxyphenyl)propyl)(methyl)amino) propyl)-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-benzo[d]azepin-2-one hydrochloride |
|
|
![4-Methoxy-3,5-diMethylpyridine 1-Oxide](/CAS/20150408/GIF/91219-89-5.gif) |
4-Methoxy-3,5-diMethylpyridine 1-Oxide |
91219-89-5 |
C8H11NO2 |
![N-Ethyl-3-buteno-o-toluidide](/CAS/20180808/GIF/13936-71-5.gif) |
N-Ethyl-3-buteno-o-toluidide |
13936-71-5 |
C13H17NO |
![Pramipexole Impurity 21](/CAS/20180808/GIF/104617-86-9.gif) |
Pramipexole Impurity 21 |
104617-86-9 |
C10H17N3S |
![Tigecycline Pentacyclic Analog](/CAS/20180808/GIF/1268494-40-1.gif) |
Tigecycline Pentacyclic Analog |
1268494-40-1 |
C27H32N4O9 |
![Tigecycline (open C-ring D-ring) Quinone](/CAS/20200515/GIF/1268494-46-7.gif) |
Tigecycline (open C-ring D-ring) Quinone |
1268494-46-7 |
C26H32N4O8 |
![Pazopanib iMpurity](/) |
Pazopanib iMpurity |
|
|
![Acetic acid, 2-[2-[2-[4-[(4- chlorophenyl)phenylMethyl]-1-piperazinyl]ethoxy]ethoxy]-](/CAS/20150408/GIF/682323-77-9.gif) |
Acetic acid, 2-[2-[2-[4-[(4- chlorophenyl)phenylMethyl]-1-piperazinyl]ethoxy]ethoxy]- |
682323-77-9 |
C23H29ClN2O4 |
![edaravone iMpurity](/) |
edaravone iMpurity |
|
|
![(2R,3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)Methyl)-4-Methylphenyl)-6-(hydroxyMethyl)tetrahydro-2H-pyran-3,4,5-triol](/CAS/20150408/GIF/CB62715715.gif) |
(2R,3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)Methyl)-4-Methylphenyl)-6-(hydroxyMethyl)tetrahydro-2H-pyran-3,4,5-triol |
|
C24H25FO5S |
![5-(4-fluorophenyl)-1H-pyrrole-3-carbaldehyde](/CAS/20150408/GIF/CB62716550.gif) |
5-(4-fluorophenyl)-1H-pyrrole-3-carbaldehyde |
|
C11H8FNO |
![Ganciclovir EP Impurity H](/CAS/20150408/GIF/84222-50-4.gif) |
Ganciclovir EP Impurity H |
84222-50-4 |
C9H13N5O4 |
![2-[4-[(1E)-1,2-Diphenylethenyl]phenoxy]-N,N-dimethylethanamine](/CAS/20150408/GIF/97151-10-5.gif) |
2-[4-[(1E)-1,2-Diphenylethenyl]phenoxy]-N,N-dimethylethanamine |
97151-10-5 |
C24H25NO |
![[S-(R*,R*)]-3,3'-Dithiobis[2-methylpropanoic acid]](/CAS/20150408/GIF/65134-74-9.gif) |
[S-(R*,R*)]-3,3'-Dithiobis[2-methylpropanoic acid] |
65134-74-9 |
C8H14O4S2 |